{"id":"arxiv/2611.22907","url":"https://arxiv.org/abs/2611.22907","tags":["q-bio.QM","math.OC"],"score":0,"title":"Optimising Recruitment and Sample Allocation in Multi-Site Rare Disease Studies","domain":"q-bio.QM","source":"arxiv","authors":["Farid Zare","Catherine Clancy","Tal Dattner","Martina Messina","Julian Teinert","Jack McGoldrick","Pavel Ješina","Sabine Weller Grønborg","Ute Spiekerkoetter","James J O'Byrne","Trine Tangeraas","Maria Luz Couce","José A. Cocho","Javier de las Heras","Niklas Darin","Dorothea Möslinger","Peter Witters","Ina Knerr","Giancarlo La Marca","Ans T. van der Ploeg","Hidde H. Huidekoper","Terry G. J. Derks","Francjan J. van Spronsen","Sandra D. K Kingma","Anibh M. Das","Carlo Dionisi-Vici","Clara D. van Karnebeek","Julia B. Hennermann","Siobhán O'Sullivan","Sabine A. Fuchs","Luciana Hannibal","M. Rebecca Heiner-Fokkema","Marek J. Noga","Irene M. L. W. Körver-Keularts","Katja Benedikte Prestø Elgstøen","George J. G. Ruijter","J J M Jans","Amy Harms","Thomas Hankemeier","Maurizio Scarpa","Ines Thiele","Shamima Rahman","Stefan Kölker","Ronan M. T. Fleming"],"reviews":0,"subject":"q-bio.QM","summary":"Clinical research in rare diseases is challenged by the limited availability and broad geographical distribution of eligible patients. This necessitates multi-centre collaboration and strategic selection of analytical laboratories based on capacity, cost, and capability. We present a mathematical framework based on cardinality optimisation to support key operational decisions in study design, balancing clinical relevance, feasibility, budgetary constraints, and logistical factors. The framework was implemented in the Reconstruction and Computational Modelling for Inherited Metabolic Diseases…","category":"research","comments":0,"disputed":false,"division":"q-bio","mentions":0,"discussed":0,"published":"2026-11-17","reactions":{}}